Oramed Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ORMP Nasdaq 2834 www.oramed.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Oramed Pharmaceuticals Inc.

3 Promising Penny Stocks With Market Caps Under $200M - Jan 14th, 2026 5:05 am
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company - Jan 13th, 2026 6:00 am
Oramed and Lifeward Announce Strategic Transaction - Jan 13th, 2026 5:58 am
Oramed Receives $18 Million Payment from Scilex Holdings, Bringing Current Returns to $118 Million; Board Approves Dividend Payments - Jan 7th, 2026 6:55 am
Oramed Pharmaceuticals And 2 Other Promising Penny Stocks To Watch - Dec 16th, 2025 5:05 am
ORMP: Advancing Clinical Activities, Generating Gains From Investment Portfolio, New Rights Plan Adopted - Nov 24th, 2025 6:26 am
There Are Some Holes In Oramed Pharmaceuticals' (NASDAQ:ORMP) Solid Earnings Release - Nov 21st, 2025 4:27 am
Oramed Reports Fiscal Third Quarter 2025 Financial Results - Nov 17th, 2025 6:55 am
ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS - Nov 17th, 2025 6:50 am
Oramed: Q3 Earnings Snapshot - Nov 13th, 2025 3:51 pm
The past three years for Oramed Pharmaceuticals (NASDAQ:ORMP) investors has not been profitable - Oct 28th, 2025 5:42 am
Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives - Oct 23rd, 2025 6:55 am
Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase - Oct 1st, 2025 7:00 am
Oramed: Q2 Earnings Snapshot - Aug 14th, 2025 4:40 pm
With Substantial Liquidity, ORMP Has Generated Gains & Income From Investment Portfolio - Jul 28th, 2025 11:05 am
We're Not Very Worried About Oramed Pharmaceuticals' (NASDAQ:ORMP) Cash Burn Rate - Jun 27th, 2025 4:15 am
Oramed: Q1 Earnings Snapshot - May 15th, 2025 4:16 pm
Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical - Apr 28th, 2025 7:00 am
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals - Apr 28th, 2025 7:00 am
ORMP: Upcoming Expected Milestones Include OraTech Spin-Off & IPO, Launch of Phase 3 Trial - Apr 3rd, 2025 3:56 am